Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen
| Conditions: | Non-small Cell Lung Cancer|Mesothelioma|Lung Neoplasms |
| Start Date: | December 1, 2006 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00316225 |
| Study Type: | Interventional |
| Intervention: | Drug: pemetrexed |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | Has Results |
| Sponsors: | Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 31 |
| Funded By: | Industry |
| First Received: | April 18, 2006 |
| End Date: | March 1, 2009 |
| Last Updated: | June 10, 2010 |
| Last Verified: | June 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
